X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CLINICAL AND EXPERIMENTAL HYPERTENSION

期刊標題檢索 CLIN EXP HYPERT 最新評論: Review speed: 3.0 | Submission success rate: 50.0 Experience sharing... (2024-07-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CLINICAL AND EXPERIMENTAL HYPERTENSION]您好,您是該頁面的第 26985 位訪客。

期刊簡介
期刊名稱CLINICAL AND EXPERIMENTAL HYPERTENSION CLINICAL AND EXPERIMENTAL HYPERTENSION
LetPub Score
5.2
50 ratings
Rate

Reputation
6.4

Influence
3.8

Speed
7.0

期刊簡稱CLIN EXP HYPERTENS
ISSN1064-1963
E-ISSN1525-6006
h-index45
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.900.4480.502
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Internal Medicine
Q278 / 167
Category: Medicine
Subcategory: Physiology
Q3123 / 193

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Serving as an international forum for the exchange of state-of-the-art scientific and clinical information on all aspects of human and animal hypertension, this authoritative journal publishes full articles as well as solicited and unsolicited reviews and commentaries that extend current understanding as well as facilitate the timely and successful detection, management, control, and prevention of hypertension-related conditions.

Features special issues covering proceedings of symposia on hypertension research!

Clinical and Experimental Hypertension maintains a rapid communications format that brings readers new and important research and findings in a prompt and reliable publication schedule in areas, including:

antihypertensive agents
circulatory control
drug development and application
etiology
mechanisms of action
neurogenic mechanisms
pathophysiology
pharmacological and nonpharmacological treatment
and much more!
官方網站http://informahealthcare.com/journal/ceh
在線稿件提交 http://mc.manuscriptcentral.com/lceh
開放訪問No
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1993
每年文章數77每年文章數趨勢
黃金OA百分比37.12%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PERIPHERAL VASCULAR DISEASESCIEQ367/96
PHARMACOLOGY & PHARMACYSCIEQ3265/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1064-1963%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【CLINICAL AND EXPERIMENTAL HYPERTENSION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CIRCULATIONH-index: 570

    CiteScore: 45.70
    CIRCULATION RESEARCHH-index: 306

    CiteScore: 29.60
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYH-index: 251

    CiteScore: 15.60
    HYPERTENSIONH-index: 246

    CiteScore: 15.90
    International Journal of StrokeH-index: 59

    CiteScore: 13.90
    JOURNAL OF THROMBOSIS AND HAEMOSTASISH-index: 154

    CiteScore: 24.30
    THROMBOSIS AND HAEMOSTASISH-index: 178

    CiteScore: 11.90
    ATHEROSCLEROSISH-index: 159

    CiteScore: 9.80
    HYPERTENSION RESEARCHH-index: 78

    CiteScore: 7.40
    CURRENT HYPERTENSION REPORTSH-index: 63

    CiteScore: 10.50
    學科內最受檢索的期刊 頁面查看次數
    CIRCULATION118511
    CIRCULATION RESEARCH93191
    HYPERTENSION80489
    ATHEROSCLEROSIS77479
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY66783
    JOURNAL OF HYPERTENSION51917
    THROMBOSIS RESEARCH43998
    HYPERTENSION RESEARCH42956
    THROMBOSIS AND HAEMOSTASIS38952
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS35896
  •  

    CLINICAL AND EXPERIMENTAL HYPERTENSION CLINICAL AND EXPERIMENTAL HYPERTENSION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CLINICAL AND EXPERIMENTAL HYPERTENSION] 的評論撰寫評論
作者: 千斤青枫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-04 19:10:05 評論於
Review speed: 3.0 | Submission success rate: 50.0 Experience sharing: ... hoping to receive.
(0) 讚! | 千斤青枫

作者: 辉夜芳蕤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 16:15:55 評論於
Just checked on the WOS official website
(0) 讚! | 辉夜芳蕤

作者: 辉夜芳蕤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 11:29:57 評論於
The other plugins have also been updated... everything has been restored
(0) 讚! | 辉夜芳蕤

作者: 缠丝志煜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-30 22:18:32 評論於
Please translate the following passage into English and Japanese, and use ":" and ":" as headings: Urgent help needed
(0) 讚! | 缠丝志煜

作者: 缠丝志煜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-30 11:02:12 評論於
Are you sure? How did you check?
(0) 讚! | 缠丝志煜

作者: 缠丝志煜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-30 08:21:49 評論於
The reunion is approaching, and I don't know what to do now
(0) 讚! | 缠丝志煜

作者: 辉夜芳蕤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-26 10:29:39 評論於
It's 2.6, WOS has been updated.. Other plugins have not been updated yet
(0) 讚! | 辉夜芳蕤

作者: 北马元洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-16 14:18:14 評論於
Review speed: 2.0 | Submission acceptance rate: 75.0

Feedback sharing: Submitted at the beginning of January, received minor revisions in mid-March, accepted after 5 days of revisions, and published online in early April. The efficiency is very good. The reviewer's comments were quite fair, without deliberately causing difficulties. Now we need to pay the publication fee!
(0) 讚! | 北马元洲

作者: 帅红来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-13 17:34:32 評論於
Just received a paper, haven't paid the page charges yet, checked on Web of Science, impact factor is 2.6, while other platforms show 12.3. Does anyone know what's going on?
(0) 讚! | 帅红来了

作者: 墟散清安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-21 16:06:47 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0
Focused research direction: Clinical hypertension; Hypertension experience sharing: I have been researching hypertension for 22 years. How come I only received 2 points for my submission last time, but now I suddenly received over 12 points this year? ?
(0) 讚! | 墟散清安

作者: 珉林惜风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-29 09:30:18 評論於
Heavy research direction: Hypertension
Experience sharing: Is the current period fast?
(0) 讚! | 珉林惜风

作者: 京城斐然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-19 13:46:15 評論於
Please translate the following passage into English and Japanese, and use ":" as the heading
(0) 讚! | 京城斐然

作者: 巴蜀向真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-10 13:54:22 評論於
Why did it suddenly rise so high, can it be sustained?
(0) 讚! | 巴蜀向真

作者: Ralap Joule


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-05 23:43:15 評論於
"Review speed: 3.0 Emphasis on research direction: hypertension Experience sharing: From two points, it soared to 12 points in one go, a local chicken turned into a phoenix. The comrades who submitted last year must be laughing their heads off."
(0) 讚! | Ralap Joule

作者: 排云栾诺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-21 21:17:49 評論於
No, maybe you chose color printing
(0) 讚! | 排云栾诺

作者: 兰花松浩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-16 16:42:02 評論於
Do I not need a layout fee, then why do I have to submit?
(0) 讚! | 兰花松浩

作者: 排云栾诺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-31 18:08:45 評論於
Review speed: 3.0 | Submission hit rate: 75.0 Research focus: Clinical direction of hypertension; sharing experience on hypertension: The impact factor for the new year is just over 2, increased slightly. Submitted a meta-analysis of the integrated treatment of hypertension with traditional Chinese and Western medicine, which I felt was written very simply. The initial review and external review took a total of three months, urged once, with only one reviewer. The reviewer's feedback was very positive, with minimal revisions. However, the review process was very slow, it felt like the feedback came back early but was not processed continuously, with no need for publication fee
(0) 讚! | 排云栾诺

作者: 先天优扬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-14 13:13:16 評論於
How are you doing now?
(0) 讚! | 先天优扬

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:30:48 評論於
The corresponding author is the overall leader of the project, responsible for the project's funding, design, writing of articles, and quality control. They are also responsible for communicating with the journal during submission, peer review, and the entire publication process
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:22:59 評論於
The corresponding author of a SCI journal paper does not necessarily have to be only one person. There is no fixed standard on the specific number of corresponding authors because different SCI journals have different policies on the number of corresponding authors. For SCI journals that only accept one corresponding author, if the paper lists multiple corresponding authors, the first corresponding author listed will be automatically selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same principle applies to other requirements - the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of a SCI paper is the person who has made the greatest contribution to the experiment and writing of the article, and is the person listed first in the author column. However, in collaborative works, it is common to have co-first authors. There is no clear rule on the number of co-first authors, and it greatly depends on the workload, length of the paper, publication guidelines, and recognition of the institution. In general, a SCI paper can have 2-4 first authors
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 23:40:05 評論於
What is the corresponding author?
(0) 讚! | 北国博达

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 16:43:39 評論於
How many corresponding authors/ first authors can a journal have?
(0) 讚! | 破戒阳平

作者: Elmer Lindsay


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-17 13:57:25 評論於
It's been five months and still no results, it's over, asking is useless!
(0) 讚! | Elmer Lindsay

作者: Elmer Lindsay


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-04 22:36:12 評論於
Where do online authors come from?
(0) 讚! | Elmer Lindsay

作者: Elmer Lindsay


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-04 17:25:03 評論於
Where is the table?
(0) 讚! | Elmer Lindsay

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CLINICAL AND EXPERIMENTAL HYPERTENSION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*